David Kirske - Jun 30, 2021 Form 4 Insider Report for CTI BIOPHARMA CORP (CTIC)

Role: EVP, Chief Financial Officer
Signature: /s/ David Kirske
Stock symbol: CTIC
Transactions as of: Jun 30, 2021
Transactions value $: $7,617
Form type: 4
Date filed: 3/11/2022, 06:41 PM
Next filing: Jun 16, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CTIC	Common Stock	Award	$3.79K	+1.78K	+46.92%	$2.13	5.58K	Jun 30, 2021	Direct	F1
transaction	CTIC	Common Stock	Award	$3.83K	+1.82K	+32.56%	$2.11	7.4K	Dec 31, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CTIC	Stock Option (right to buy)	Award	$0	+280K		$0.00	280K	Mar 9, 2022	Common Stock	280K	$4.49	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares acquired under the CTI BioPharma Corp. 2007 Employee Stock Purchase Plan.
F2	The stock option will vest in six equal semi-annual installments over a three-year period, subject to continued employment with the Company through the applicable vesting dates.